efferalgan c 330 mg/200 mg putojošās tabletes
upsa sas, france - paracetamolum, skābes ascorbicum - putojošā tablete - 330 mg/200 mg
efferalgan 80 mg supozitoriji
upsa sas, france - paracetamols - supozitorijs - 80 mg
efferalgan 150 mg supozitoriji
upsa sas, france - paracetamols - supozitorijs - 150 mg
efferalgan 30 mg/ml šķīdums iekš ķīgai lietošanai bērniem
upsa sas, france - paracetamols - Šķīdums iekšķīgai lietošanai - 30 mg/ml
efferalgan 500 mg putojošās tabletes
upsa sas, france - paracetamols - putojošā tablete - 500 mg
belfer
bela-pharm gmbh&co.kg, vācija - dzelzs (iii) hydroxidum ar dextranum - šķīdums injekcijām - 100 mg/ml - aitas; cūkas; kazas; liellopi; suņi; zirgi
apcvit 1000 mg effervescent tablets orange (2020.) tablete
sia "aptiekas produkcija" - tablete
apcvit 1000 mg effervescent tablets lemon (2020.) tablete
sia "aptiekas produkcija" - tablete
olimp labs® gold-vit® c 2000 (effertabs) (2023.) tablete, putojošas tabletes
tablete, putojošas tabletes
lutetium (177lu) chloride billev (previously illuzyce)
billev pharma aps - lutetium (177lu) chloride - radionuklīdu attēlveidošana - terapeitiskie radiofarmaceitiskie preparāti - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.